Enact Holdings, Inc.
US ˙ NasdaqGS ˙ US29249E1091

Introduction

This page provides a comprehensive analysis of the known insider trading history of Thomas C Freyman. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Thomas C Freyman has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ABBV / AbbVie Inc. Director 126,751
US:880370BP5 / Tenneco Inc Debentures 7.25% 12/15/25 Director 0
US:HNGR / Hanger Inc Director 0
US:ACT / Enact Holdings, Inc. Director 0
US:ABT / Abbott Laboratories Executive Vice President 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Thomas C Freyman. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ACT / Enact Holdings, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ACT / Enact Holdings, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2018-08-30 AGN FREYMAN THOMAS C 1,100 190.6900 1,100 190.6900 209,759 34

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ACT / Enact Holdings, Inc. Insider Trades
Insider Sales ACT / Enact Holdings, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ACT / Enact Holdings, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ACT / Enact Holdings, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Thomas C Freyman as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-05-13 2025-05-09 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
A - Award 1,203 126,751 0.96
2024-05-07 2024-05-03 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
A - Award 1,322 125,548 1.06
2023-05-09 2023-05-05 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
A - Award 1,450 124,226 1.18
2022-11-21 2022-11-17 4 TEN TENNECO INC
Class A Common Stock
D - Sale to Issuer -93,892 0 -100.00 20.00 -1,877,840
2022-10-04 2022-10-03 4 HNGR HANGER, INC.
Common Stock
D - Sale to Issuer -43,561 0 -100.00 18.75 -816,769
2022-06-03 2022-06-02 4 HNGR HANGER, INC.
Common Stock
A - Award 9,911 43,561 29.45
2022-05-09 2022-05-06 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
A - Award 1,421 122,776 1.17
2022-02-02 2022-02-01 4 TEN TENNECO INC
Class A Common Stock
A - Award 15,110 93,892 19.18
2021-05-27 2021-05-26 4 HNGR HANGER, INC.
Common Stock
A - Award 5,484 33,650 19.47
2021-05-11 2021-05-07 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
A - Award 1,681 121,355 1.40
2021-02-04 2021-02-02 4 TEN TENNECO INC
Class A Common Stock
A - Award 10,850 78,782 15.97
2020-08-07 2020-08-07 4 TEN TENNECO INC
Class A Common Stock
P - Purchase 30,000 67,932 79.09 7.70 231,000 523,076
2020-05-22 2020-05-08 4/A ABBV AbbVie Inc.
Common Stock, $0.01 par value
A - Award 2,333 119,675 1.99
2020-05-22 2020-05-08 4/A ABBV AbbVie Inc.
Common Stock, $0.01 par value
A - Award 2,583 117,342 2.25
2020-05-22 3/A ABBV AbbVie Inc.
Common Stock, $0.01 par value
114,759
2020-05-22 3/A ABBV AbbVie Inc.
Common Stock, $0.01 par value
4,000
2020-05-22 3/A ABBV AbbVie Inc.
Common Stock, $0.01 par value
1,941
2020-05-22 3/A ABBV AbbVie Inc.
Common Stock, $0.01 par value
1,941
2020-05-21 2020-05-20 4 HNGR HANGER, INC.
Common Stock
A - Award 8,178 28,166 40.91
2020-05-12 3 ABBV AbbVie Inc.
Common Stock, $0.01 par value
233,518
2020-05-12 3 ABBV AbbVie Inc.
Common Stock, $0.01 par value
122,759
2020-05-12 3 ABBV AbbVie Inc.
Common Stock, $0.01 par value
233,518
2020-05-12 3 ABBV AbbVie Inc.
Common Stock, $0.01 par value
122,759
2020-05-12 3 ABBV AbbVie Inc.
Common Stock, $0.01 par value
233,518
2020-05-12 3 ABBV AbbVie Inc.
Common Stock, $0.01 par value
122,759
2020-05-12 2020-05-08 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
A - Award 2,333 119,675 1.99
2020-05-12 2020-05-08 4 ABBV AbbVie Inc.
Common Stock, $0.01 par value
A - Award 2,583 117,342 2.25
2020-05-12 3/A ABBV AbbVie Inc.
Common Stock, $0.01 par value
114,759
2020-05-12 3/A ABBV AbbVie Inc.
Common Stock, $0.01 par value
4,000
2020-05-11 2020-05-08 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
D - Sale to Issuer -2,983 0 -100.00
2020-05-04 2020-05-01 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
F - Taxes -2,064 2,983 -40.90 189.74 -391,623 565,994
2020-02-06 2020-02-04 4 TEN TENNECO INC
Class A Common Stock
A - Award 12,208 37,932 47.46
2019-05-24 2019-05-23 4 HNGR HANGER, INC.
Common Stock
A - Award 6,969 19,988 53.53
2019-05-02 2019-05-02 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
A - Award 2,064 3,974 108.06 145.33 299,961 577,541
2019-05-02 2019-04-30 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
F - Taxes -748 1,910 -28.14 147.00 -109,956 280,770
2019-02-07 2019-02-05 4 TEN TENNECO INC
Class A Common Stock
A - Award 3,459 25,724 15.54
2018-09-04 2018-08-30 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 1,100 2,658 70.60 190.69 209,759 506,854
2018-08-10 2018-08-09 4 TEN TENNECO INC
Common Stock
P - Purchase 5,000 22,265 28.96 44.49 222,450 990,570
2018-06-15 2018-06-13 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
A - Award 1,558 1,558 170.23 265,218 265,218
2018-05-17 2018-05-16 4 HNGR HANGER, INC.
Common Stock
A - Award 7,672 13,019 143.48
2018-02-09 2018-02-07 4 TEN TENNECO INC
Common Stock
A - Award 2,180 17,265 14.45
2017-11-17 2017-11-15 4 HGR HANGER, INC.
Common Stock
A - Award 5,347 5,347
2017-02-03 2017-02-01 4 TEN TENNECO INC
Common Stock
A - Award 1,756 15,085 13.17
2016-08-04 2016-08-03 4 TEN TENNECO INC
Common Stock
J - Other -2,757 0 -100.00
2016-08-04 2016-08-03 4 TEN TENNECO INC
Common Stock
J - Other 2,757 13,329 26.08
2016-07-29 2016-07-29 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -56,000 0 -100.00
2016-07-29 2016-07-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -42,863 395,819 -9.77 44.45 -1,905,260 17,594,155
2016-07-29 2016-07-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 56,000 438,682 14.63 25.25 1,413,782 11,075,010
2016-03-02 2016-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -19,908 382,682 -4.94 39.52 -786,764 15,123,593
2016-02-23 2016-02-19 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 485,159 485,159
2016-02-23 2016-02-19 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 55,338 402,590 15.94
2016-02-05 2016-02-03 4 TEN TENNECO INC
Common Stock
A - Award 2,757 2,757
2015-07-15 2015-07-14 4 TEN TENNECO INC
Common Stock
J - Other -2,000 0 -100.00
2015-07-15 2015-07-14 4 TEN TENNECO INC
Common Stock
J - Other 2,000 10,572 23.33
2015-03-03 2015-02-27 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -22,797 347,252 -6.16 47.61 -1,085,365 16,532,668
2015-02-24 2015-02-20 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 284,857 284,857
2015-02-24 2015-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 40,425 370,049 12.26
2015-01-16 2015-01-14 4 TEN TENNECO INC
Common Stock
A - Award 2,000 2,000
2014-07-22 2014-07-21 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -56,000 56,000 -50.00
2014-07-22 2014-07-21 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -23,000 0 -100.00
2014-07-22 2014-07-21 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -60,702 329,624 -15.55 42.73 -2,593,796 14,084,834
2014-07-22 2014-07-21 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 56,000 390,326 16.75 25.25 1,413,782 9,854,209
2014-07-22 2014-07-21 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 23,000 334,326 7.39 21.22 488,046 7,094,197
2014-07-16 2014-07-15 4 TEN TENNECO INC
Common Stock
J - Other -1,589 0 -100.00
2014-07-16 2014-07-15 4 TEN TENNECO INC
Common Stock
J - Other 1,589 8,572 22.76
2014-03-04 2014-03-03 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -2,984 311,326 -0.95 39.10 -116,686 12,174,092
2014-03-04 2014-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -27,660 314,310 -8.09 39.79 -1,100,591 12,506,395
2014-02-25 2014-02-21 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 200,477 200,477
2014-02-25 2014-02-21 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 32,746 341,970 10.59
2014-01-17 2014-01-15 4 TEN TENNECO INC
Common Stock
A - Award 1,589 1,589
2013-10-23 2013-10-21 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -42,487 0 -100.00
2013-10-23 2013-10-21 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -41,059 309,224 -11.72 37.29 -1,531,090 11,530,963
2013-10-23 2013-10-21 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 42,487 350,283 13.80 34.93 1,484,071 12,235,385
2013-07-16 2013-07-16 4 TEN TENNECO INC
Common Stock
J - Other -2,483 0 -100.00
2013-07-16 2013-07-16 4 TEN TENNECO INC
Common Stock
J - Other 2,483 6,983 55.18
2013-05-03 2013-05-02 4 TEN TENNECO INC
Common Stock
P - Purchase 1,500 4,500 50.00 38.26 57,390 172,170
2013-04-03 2013-04-01 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -63,800 0 -100.00
2013-04-03 2013-04-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -50,917 307,796 -14.19 35.32 -1,798,388 10,871,355
2013-04-03 2013-04-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 63,800 358,713 21.63 22.27 1,420,635 7,987,462
2013-03-14 2013-03-12 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 42,487 42,487
2013-03-14 2013-03-12 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -16,384 0 -100.00
2013-03-14 2013-03-12 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -33,180 0 -100.00
2013-03-14 2013-03-12 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -42,487 294,913 -12.59 34.93 -1,484,071 10,301,311
2013-03-14 2013-03-12 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 16,384 337,400 5.10 26.09 427,488 8,803,373
2013-03-14 2013-03-12 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 33,180 321,016 11.53 25.25 837,825 8,105,943
2013-03-01 2013-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -28,188 287,836 -8.92 34.26 -965,721 9,861,261
2013-02-20 2013-02-19 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -15,024 316,024 -4.54 35.08 -527,042 11,086,122
2013-02-20 2013-02-15 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 299,300 299,300
2013-02-20 2013-02-15 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 57,500 331,048 21.02
2013-01-18 3 TEN TENNECO INC
Common Stock
3,000
2013-01-18 2013-01-16 4 TEN TENNECO INC
Common Stock
A - Award 2,483 2,483
2012-12-14 2012-11-16 4 ABT ABBOTT LABORATORIES
Common shares without par value
G - Gift 76,000 76,000
2012-12-14 2012-11-16 4 ABT ABBOTT LABORATORIES
Common shares without par value
G - Gift -76,000 273,548 -21.74
2012-12-14 2012-11-13 4 ABT ABBOTT LABORATORIES
Common shares without par value
G - Gift 76,000 76,000
2012-12-14 2012-11-13 4 ABT ABBOTT LABORATORIES
Common shares without par value
G - Gift -76,000 4,000 -95.00
2012-12-14 2012-11-08 4 ABT ABBOTT LABORATORIES
Common shares without par value
G - Gift 65,000 80,000 433.33
2012-12-14 2012-11-08 4 ABT ABBOTT LABORATORIES
Common shares without par value
G - Gift -65,000 349,548 -15.68
2012-12-07 3 ABBV AbbVie Inc.
Common stock, $0.01 par value
0
2012-09-25 2012-09-21 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -30,000 23,000 -56.60
2012-09-25 2012-09-21 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -23,538 414,548 -5.37 69.86 -1,644,365 28,960,323
2012-09-25 2012-09-21 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 30,000 438,086 7.35 44.16 1,324,800 19,345,878
2012-07-25 2012-07-23 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -30,000 53,000 -36.14
2012-07-25 2012-07-23 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -24,357 408,086 -5.63 65.06 -1,584,666 26,550,075
2012-07-25 2012-07-23 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 30,000 432,443 7.45 44.16 1,324,800 19,096,683
2012-05-04 2012-05-03 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -25,602 0 -100.00
2012-05-04 2012-05-03 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -24,705 402,443 -5.78 62.65 -1,547,768 25,213,054
2012-05-04 2012-05-03 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 25,602 427,148 6.38 58.90 1,507,958 25,159,017
2012-03-22 2012-03-20 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -25,701 0 -100.00
2012-03-22 2012-03-20 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -26,572 0 -100.00
2012-03-22 2012-03-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -24,314 401,546 -5.71 60.22 -1,464,189 24,181,100
2012-03-22 2012-03-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -24,590 425,860 -5.46 60.22 -1,480,810 25,645,289
2012-03-22 2012-03-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 25,701 450,450 6.05 54.67 1,405,074 24,626,102
2012-03-22 2012-03-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 26,572 424,749 6.67 52.55 1,396,359 22,320,560
2012-03-02 2012-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -27,207 398,177 -6.40 57.04 -1,551,887 22,712,016
2012-02-22 2012-02-17 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 107,300 107,300
2012-02-22 2012-02-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 59,400 425,384 16.23
2006-02-22 2006-02-18 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -1,223 196,442 -0.62 44.15 -53,995 8,672,914
2006-02-22 2006-02-17 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 83,000 83,000
2006-02-22 2006-02-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 28,600 225,042 14.56 44.16 1,262,976 9,937,855
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)